MRI Embeddings Complement Clinical Predictors for Cognitive Decline Modeling in Alzheimer's Disease Cohorts
This work addresses Alzheimer's disease progression modeling for clinicians and researchers, offering incremental insights by showing complementary strengths of different modalities.
The study tackled the problem of modeling cognitive decline in Alzheimer's disease by evaluating tabular and MRI-based predictors, finding that clinical features achieved AUCs around 0.70 for predicting progression extremes, while transformer-derived MRI embeddings achieved an AUC of 0.71 for distinguishing stable individuals.
Accurate modeling of cognitive decline in Alzheimer's disease is essential for early stratification and personalized management. While tabular predictors provide robust markers of global risk, their ability to capture subtle brain changes remains limited. In this study, we evaluate the predictive contributions of tabular and imaging-based representations, with a focus on transformer-derived Magnetic Resonance Imaging (MRI) embeddings. We introduce a trajectory-aware labeling strategy based on Dynamic Time Warping clustering to capture heterogeneous patterns of cognitive change, and train a 3D Vision Transformer (ViT) via unsupervised reconstruction on harmonized and augmented MRI data to obtain anatomy-preserving embeddings without progression labels. The pretrained encoder embeddings are subsequently assessed using both traditional machine learning classifiers and deep learning heads, and compared against tabular representations and convolutional network baselines. Results highlight complementary strengths across modalities. Clinical and volumetric features achieved the highest AUCs of around 0.70 for predicting mild and severe progression, underscoring their utility in capturing global decline trajectories. In contrast, MRI embeddings from the ViT model were most effective in distinguishing cognitively stable individuals with an AUC of 0.71. However, all approaches struggled in the heterogeneous moderate group. These findings indicate that clinical features excel in identifying high-risk extremes, whereas transformer-based MRI embeddings are more sensitive to subtle markers of stability, motivating multimodal fusion strategies for AD progression modeling.